Table 2 Univariate analysis of estimated survival from time of liver resection (Kaplan-Meier)
Survival from time of liver resection | ||||
|---|---|---|---|---|
Parameter | n | 5-year | 10-year | p value |
Overall survival | 100 | 56.8% | 34.3% | – |
Age | ||||
> 60 years | 49 | 62.10% | 35.40% | 0.669 |
≤ 60 years | 51 | 52.10% | 34.80% | |
Gender specific tumor | ||||
None female only | 70 | 56.60% | 37.20% | 0.659 |
Female only | 30 | 57.30% | 30.60% | |
Hepatic margin | ||||
Negative | 93 | 60% | 34.40% | 0.07 |
Positive | 7 | 17.90% | 17.90% | |
Time of liver resection | ||||
Interval resection | 87 | 60.30% | 35.10% | 0.037 |
Simultaneous (with primary) | 13 | 32.40% | 32.40% | |
Residual disease | ||||
No residual tumor | 90 | 60.70% | 35.30% | 0.02 |
Residual tumor | 10 | 23.30% | 23.30% | |
Gender | ||||
Male | 40 | 69.90% | 51% | 0.013 |
Female | 60 | 49.60% | 25.70% | |
Embryologic origin | ||||
Mesodermal | 44 | 66.60% | 41% | |
Ectodermal | 29 | 56.30% | 21.10% | 0.009 |
Entodermal | 27 | 29.30% | 29.30% | |
Onset of metastatic disease | ||||
> 24 months | 50 | 73.20% | 44.10% | 0.002 |
≤ 24 months | 50 | 39.60% | 19.80% | |